Bausch Health Companies Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Bausch Health Companies Inc. (BHC) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$23.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2023-11-02
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-09-30 was -$8.00M, a 900.00% decline year-over-year.
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-06-30 was -$9.00M.
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-03-31 was -$6.00M, a 400.00% decline year-over-year.
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2022-09-30 was $1.00M.
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for fiscal 2017 was $106.00M.
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for fiscal 2016 was -$14.00M.
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for fiscal 2014 was -$135.00M.
- Bausch Health Companies Inc. foreign currency transaction gain (loss), unrealized for fiscal 2013 was -$9.80M, a 141.18% decline from fiscal 2012.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 3 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 12 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | -$8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$17.00M derived: sum of 2 quarters · filed 2023-11-02 | -$23.00M 10-Q · filed 2023-11-02 | |||||
| 2023-06-30 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$15.00M 10-Q · filed 2023-08-03 | ||||||
| 2023-03-31 | -$6.00M 10-Q · filed 2023-05-04 | |||||||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.00M derived: sum of 2 quarters · filed 2023-11-02 | $1.00M 10-Q · filed 2023-11-02 | $3.00M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $2.00M derived: sum of 3 quarters · filed 2023-08-03 | $1.00M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $2.00M 10-Q · filed 2023-05-04 | $4.00M derived: sum of 2 quarters · filed 2023-05-04 | $3.00M derived: sum of 3 quarters · filed 2023-05-04 | $8.00M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $2.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $1.00M derived: sum of 2 quarters · filed 2022-11-03 | $6.00M derived: sum of 3 quarters · filed 2022-11-03 | -$6.00M 8-K · filed 2022-05-11 | ||||
| 2021-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.00M derived: sum of 2 quarters · filed 2022-11-03 | -$8.00M 10-Q · filed 2022-11-03 | -$2.00M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$7.00M 10-Q · filed 2022-08-09 | -$1.00M derived: sum of 3 quarters · filed 2022-08-09 | -$4.00M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$12.00M 10-Q · filed 2022-05-10 | -$6.00M derived: sum of 2 quarters · filed 2022-05-11 | -$9.00M derived: sum of 3 quarters · filed 2022-05-11 | -$4.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $6.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $3.00M derived: sum of 2 quarters · filed 2022-05-11 | $8.00M derived: sum of 3 quarters · filed 2022-05-11 | -$8.00M 8-K · filed 2022-05-11 | ||||
| 2020-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $2.00M derived: sum of 2 quarters · filed 2021-11-02 | -$14.00M 10-Q · filed 2021-11-02 | -$13.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$11.00M 10-Q · filed 2021-08-03 | -$10.00M derived: sum of 3 quarters · filed 2022-05-11 | -$20.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | -$16.00M 10-Q · filed 2021-05-04 | -$15.00M derived: sum of 2 quarters · filed 2022-05-11 | -$25.00M derived: sum of 3 quarters · filed 2022-05-11 | -$23.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $1.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$9.00M derived: sum of 2 quarters · filed 2022-05-11 | -$7.00M derived: sum of 3 quarters · filed 2022-05-11 | -$7.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$8.00M derived: sum of 2 quarters · filed 2020-11-03 | -$8.00M 10-Q · filed 2020-11-03 | -$5.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.00M 10-Q · filed 2020-08-06 | $5.00M derived: sum of 3 quarters · filed 2021-05-04 | $6.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $3.00M derived: sum of 2 quarters · filed 2021-05-04 | $4.00M derived: sum of 3 quarters · filed 2021-05-04 | -$6.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $3.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $4.00M derived: sum of 2 quarters · filed 2021-05-04 | -$6.00M derived: sum of 3 quarters · filed 2021-05-04 | $19.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$9.00M derived: sum of 2 quarters · filed 2019-11-04 | $16.00M 10-Q · filed 2019-11-04 | $39.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $15.00M 10-Q · filed 2019-08-06 | $38.00M derived: sum of 3 quarters · filed 2020-02-19 | $51.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $25.00M 10-Q · filed 2019-05-06 | $48.00M derived: sum of 2 quarters · filed 2020-02-19 | $61.00M derived: sum of 3 quarters · filed 2020-02-19 | $100.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $36.00M derived: sum of 2 quarters · filed 2020-02-19 | $75.00M derived: sum of 3 quarters · filed 2020-02-19 | $106.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $52.00M derived: sum of 2 quarters · filed 2018-11-06 | $83.00M 10-Q · filed 2018-11-06 | $54.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $39.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $70.00M 10-Q · filed 2018-08-07 | $41.00M derived: sum of 3 quarters · filed 2019-02-20 | $40.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $31.00M 10-Q · filed 2018-05-08 | $2.00M derived: sum of 2 quarters · filed 2019-02-20 | $1.00M derived: sum of 3 quarters · filed 2019-02-20 | $15.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$30.00M derived: sum of 2 quarters · filed 2019-02-20 | -$16.00M derived: sum of 3 quarters · filed 2019-02-20 | -$14.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $13.00M derived: sum of 2 quarters · filed 2017-11-07 | $15.00M 10-Q · filed 2017-11-07 | $14.60M 10-Q · filed 2016-11-09 | $16.60M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $16.00M 10-Q · filed 2017-08-08 | $15.50M 10-Q · filed 2016-08-09 | $17.60M derived: sum of 3 quarters · filed 2018-08-10 | -$13.40M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $2.00M 10-Q · filed 2017-05-09 | $1.80M 10-Q · filed 2016-06-07 | $3.60M derived: sum of 2 quarters · filed 2018-08-10 | -$27.40M derived: sum of 3 quarters · filed 2018-08-10 | -$17.10M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $1.60M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | -$29.40M derived: sum of 2 quarters · filed 2018-08-10 | -$19.10M derived: sum of 3 quarters · filed 2018-08-10 | -$95.00M 8-K · filed 2018-08-10 | -$95.20M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | -$31.00M 10-Q · filed 2015-10-26 | -$20.70M derived: sum of 2 quarters · filed 2015-10-26 | -$96.60M 10-Q · filed 2016-11-09 | -$169.20M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $10.30M 10-Q · filed 2015-07-28 | -$65.60M 10-Q · filed 2016-08-09 | -$138.20M derived: sum of 3 quarters · filed 2017-03-01 | -$193.30M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | -$75.90M 10-Q · filed 2016-06-07 | -$148.50M derived: sum of 2 quarters · filed 2017-03-01 | -$203.60M derived: sum of 3 quarters · filed 2017-03-01 | -$198.30M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$72.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$127.70M derived: sum of 2 quarters · filed 2017-03-01 | -$122.40M derived: sum of 3 quarters · filed 2017-03-01 | -$135.00M 10-K · filed 2017-03-01 | -$135.10M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | -$55.10M 10-Q · filed 2015-10-26 | -$49.80M derived: sum of 2 quarters · filed 2015-10-26 | -$62.40M 10-Q · filed 2015-10-26 | -$68.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $5.30M 10-Q · filed 2015-07-28 | -$7.30M 10-Q · filed 2015-07-28 | -$13.70M derived: sum of 3 quarters · filed 2016-04-29 | -$8.30M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | -$12.60M 10-Q · filed 2015-04-30 | -$19.00M derived: sum of 2 quarters · filed 2016-04-29 | -$13.60M derived: sum of 3 quarters · filed 2016-04-29 | -$24.20M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$1.00M derived: sum of 2 quarters · filed 2016-04-29 | -$11.60M derived: sum of 3 quarters · filed 2016-04-29 | -$9.80M 10-K · filed 2016-04-29 | -$9.78M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $5.40M 10-Q · filed 2014-10-24 | $5.41M 10-Q · filed 2013-11-01 | -$5.20M derived: sum of 2 quarters · filed 2014-10-24 | -$3.40M 10-Q · filed 2014-10-24 | -$3.36M 10-Q · filed 2013-11-01 | -$1.51M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | -$10.60M 10-Q · filed 2014-08-01 | -$10.54M 10-Q · filed 2013-08-07 | -$8.80M 10-Q · filed 2014-08-01 | -$8.77M 10-Q · filed 2013-08-07 | -$6.91M derived: sum of 3 quarters · filed 2015-02-25 | -$7.26M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $1.80M 10-Q · filed 2014-05-09 | $1.77M 10-Q · filed 2013-05-03 | $3.69M derived: sum of 2 quarters · filed 2015-02-25 | $3.33M derived: sum of 3 quarters · filed 2015-02-25 | $36.00K derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.53M derived: sum of 2 quarters · filed 2015-02-25 | -$1.76M derived: sum of 3 quarters · filed 2015-02-25 | $23.80M 10-K · filed 2015-02-25 | $23.84M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | -$356.00K 10-Q · filed 2013-11-01 | -$3.65M derived: sum of 2 quarters · filed 2013-11-01 | $21.91M 10-Q · filed 2013-11-01 | $26.08M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$3.30M 10-Q · filed 2013-08-07 | $22.27M 10-Q · filed 2013-08-07 | $26.43M derived: sum of 3 quarters · filed 2014-02-28 | $22.82M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $25.56M 10-Q · filed 2013-05-03 | $29.73M derived: sum of 2 quarters · filed 2014-02-28 | $26.12M derived: sum of 3 quarters · filed 2014-02-28 | $27.22M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $556.00K derived: sum of 2 quarters · filed 2014-02-28 | $1.66M derived: sum of 3 quarters · filed 2014-02-28 | $4.83M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | -$3.61M 10-Q · filed 2012-11-05 | -$2.51M derived: sum of 2 quarters · filed 2012-11-05 | $662.00K 10-Q · filed 2012-11-05 | |||||
| 2011-06-30 | $1.10M 10-Q · filed 2012-08-03 | $4.27M 10-Q · filed 2012-08-03 | ||||||
| 2011-03-31 | $3.17M 10-Q · filed 2012-05-04 | |||||||
| 2010-12-31 | $1.54M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |